E-LIB Suche - Ergebnisse für: Hebeisen, Paul

1

Investigation of morpholine isosters for the development of..:

De Pascale, Martina ; Bissegger, Lukas ; Tarantelli, Chiara...
European Journal of Medicinal Chemistry. 248 (2023) - p. 115038 , 2023

Link: https://doi.org/10.1016/..

2

Investigation of morpholine isosters for the development of..:

De Pascale, Martina ; Bissegger, Lukas ; Tarantelli, Chiara...
info:eu-repo/semantics/altIdentifier/pmid/36634458. , 2023

Link: https://hdl.handle.net/2..

3

Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR i..:

Borsari, Chiara ; Keles, Erhan ; Treyer, Andrea...
RSC Medicinal Chemistry. 12 (2021) 4 - p. 579-583 , 2021

Link: https://doi.org/10.1039/..

4

Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR i..:

Borsari, Chiara ; Keles, Erhan ; Treyer, Andrea...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128076/. , 2021

Link: http://www.ncbi.nlm.nih...

5

4-(Difluoromethyl)-5-(4-((3R,5S)-3,5-dimethylmorpholino)-6-..:

Borsari, Chiara ; Keles, Erhan ; Rageot, Denise...
Journal of Medicinal Chemistry. 63 (2020) 22 - p. 13595-13617 , 2020

Link: https://doi.org/10.1021/..

6

A systematic strategy for estimating hERG block potency and..:

Ridder, Bradley J. ; Leishman, Derek J. ; Bridgland-Taylor, Matthew...
Toxicology and Applied Pharmacology. 394 (2020) - p. 114961 , 2020

Link: https://doi.org/10.1016/..

7

Corrigendum to "A systematic strategy for estimating hERG b..:

Ridder, Bradley J. ; Leishman, Derek J. ; Bridgland-Taylor, Matthew...
Toxicology and Applied Pharmacology. 395 (2020) - p. 114983 , 2020

Link: https://doi.org/10.1016/..

8

4-(Difluoromethyl)-5-(4-((3R,5S)-3,5-dimethylmorpholino)-6-..:

Borsari, Chiara ; Keles, Erhan ; Rageot, Denise...
Journal of medicinal chemistry -- J Med Chem -- JMC -- https://pubs.acs.org/journal/jmcmar -- http://rzblx1.uni-regensburg.de/ezeit/detail.phtml?bibid=TIHO&colors=7&lang=de&jour_id=1798 -- 1491411-6 -- 1520-4804 -- 0022-2623. , 2020

Link: https://doi.org/10.1021/..

9

A systematic strategy for estimating hERG block potency and..:

Ridder, Bradley J ; Leishman, Derek J ; Bridgland-Taylor, Matthew...
https://nottingham-repository.worktribe.com/output/4198126. , 2020

Link: https://doi.org/10.1016/..

10

Corrigendum to "A systematic strategy for estimating hERG b..:

Ridder, Bradley J ; Leishman, Derek J ; Bridgland-Taylor, Matthew...
https://nottingham-repository.worktribe.com/output/4304853. , 2020

Link: https://doi.org/10.1016/..

11

A systematic strategy for estimating hERG block potency and..:

Ridder, Bradley J ; Leishman, Derek J ; Bridgland-Taylor, Matthew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166077/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Scalable, Economical, and Practical Synthesis of 4-(Difluor..:

Rageot, Denise ; Beaufils, Florent ; Borsari, Chiara...
Organic Process Research & Development. 23 (2019) 11 - p. 2416-2424 , 2019

Link: https://doi.org/10.1021/..

13

A Conformational Restriction Strategy for the Identificatio..:

Borsari, Chiara ; Rageot, Denise ; Dall'Asen, Alix...
Journal of Medicinal Chemistry. 62 (2019) 18 - p. 8609-8630 , 2019

Link: https://doi.org/10.1021/..

14

(S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholi..:

Rageot, Denise ; Bohnacker, Thomas ; Keles, Erhan...
Journal of Medicinal Chemistry. 62 (2019) 13 - p. 6241-6261 , 2019

Link: https://doi.org/10.1021/..

15

Preclinical Development of PQR514, a Highly Potent PI3K Inh..:

Borsari, Chiara ; Rageot, Denise ; Beaufils, Florent...
ACS Medicinal Chemistry Letters. 10 (2019) 10 - p. 1473-1479 , 2019

Link: https://doi.org/10.1021/..